Get Premium to unlock powerful stock data
NAS:MDGL (USA)  
Madrigal Pharmaceuticals Inc logo

Madrigal Pharmaceuticals Inc

$ 83.46 -1.19 (-1.41%) 10:08 PM EST
P/E:
At Loss
P/B:
9.78
Market Cap:
$ 1.43B
Enterprise V:
$ 1.23B
Volume:
210.38K
Avg Vol (2M):
195.02K
Also Trade In:
Volume:
210.38K
Market Cap $:
1.43B
PE Ratio:
At Loss
Avg Vol (2-Month):
195.02K
Enterprise Value $:
1.23B
PB Ratio:
9.78
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Madrigal Pharmaceuticals Inc
NAICS : 325412 SIC : 2834
200 Barr Harbor Drive, Suite 200, Four Tower Bridge, West Conshohocken, PA, USA, 19428
Description
Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed B-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Also, MGL-3196 reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action.
Name Current Vs Industry Vs History
Cash-To-Debt 316.02
Equity-to-Asset 0.66
Debt-to-Equity 0.01
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score -4.96
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 77.48
9-Day RSI 70.53
14-Day RSI 64.79
6-1 Month Momentum % -27.58
12-1 Month Momentum % -37.53

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.89
Quick Ratio 2.89
Cash Ratio 2.87

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -3.5

Financials (Next Earnings Date:2022-08-05 Est.)

MDGL's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:MDGL

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -14.65
Beta 0.9
Volatility % 80.79
14-Day RSI 64.79
14-Day ATR ($) 5.047939
20-Day SMA ($) 71.75
12-1 Month Momentum % -37.53
52-Week Range ($) 52.33 - 105.93
Shares Outstanding (Mil) 17.1

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Madrigal Pharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More